Mallinckrodt - Top 10 Generic Drug Companies 2010

MallinckrodtCompany name: Mallinckrodt
Location: Hazelwood, MO
Annual sales (in millions): $860
Market share: 2.7%
President: Charles Bramlage

Brothers Edward, Otto, and Gustav Mallinckrodt began manufacturing fine chemicals for pharmaceutical products in 1867. The company has changed since then; in 2000, it was acquired by Tyco International. Then, in early 2006, Tyco announced it was dividing the conglomerate into three separate publicly traded companies in 2007, with Mallinckrodt operating within a stand-alone healthcare company to be named Covidien.

During its most recent quarter, Covidien as a whole reported an adjusted profit that beat estimates on better margins, but saw weak pharmaceutical sales, as Reuters notes. The pharma business saw sales of $507 million, down 6 percent from last year's third-quarter sales of $539 million. And generic products posted sharply decreased sales versus last year, primarily due to increased competitive activity, which is driving lower pricing, coupled with distributor inventory contraction, according to a company statement. Executives told analysts on a conference call that they expected 2010 pharmaceutical sales to be "well below" 2009 levels, as many of Covidien's older brands are facing expanded competition, Reuters reports.

Mallinckrodt - Top 10 Generic Drug Companies 2010
Read more on

Suggested Articles

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.

In a last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat rivals.